FCRL3/FcRH3 Antibody (546828) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3126H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
HRP
Antibody Source
Monoclonal Mouse IgG1 Clone # 546828
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human FCRL3/FcRH3
Arg14-Arg569
Accession # Q96P31
Arg14-Arg569
Accession # Q96P31
Specificity
Detects human FCRL3/FcRH3 in direct ELISAs.
In direct ELISAs, less than 5%
cross-reactivity with recombinant human (rh) FCRL2 and rhFCRL5 is observed, and
no cross-reactivity with rhFCRL1 or recombinant mouse FCRL3 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for FCRL3/FcRH3 Antibody (546828) [HRP]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FCRL3/FcRH3
Long Name
Fc Receptor-like 3
Alternate Names
CD307c, FcRH3, IFGP3, IRTA3, SPAP2
Gene Symbol
FCRL3
Additional FCRL3/FcRH3 Products
Product Documents for FCRL3/FcRH3 Antibody (546828) [HRP]
Product Specific Notices for FCRL3/FcRH3 Antibody (546828) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...